Males
This term encompasses all aspects of the male biological identity, including reproductive anatomy, hormones, and secondary sexual characteristics.
Researchers can use PubCompare.ai to easily identify the most effective products and methodologies to advance their male-oriented studies, drawing on data-driven insights from the latest literature, preprints, and patents.
Most cited protocols related to «Males»
To illustrate the utility of ANNOVAR in identifying causal genes for Mendelian diseases with dominant inheritance, we synthesized whole-exome data sets. Since exome data for four Freeman–Sheldon cases were not available to us, we downloaded the exome data for eight HapMap subjects reported in (11 (link)). We then extracted the exome data for the first four subjects, including two Yoruba subjects (NA18507, NA18517) and two European Americans (NA12156 and NA12878). We next added the four known causal mutations to each of the four HapMap subjects (three C–>T mutations at chr17:10485359 and one C–>T mutation at chr17:10485360, representing R672H and R672C mutations in MYH3). We tested whether ANNOVAR can identify MYH3 as the causal gene by examining exomes from these four subjects.
Genomic DNA was extracted from the clipped tails of mice by Proteinase K lysis buffer as previously described42 (link). The genetic status of each mouse was determined from the genome analysis of the twitcher mutation, as reported in ref. 31 (link). TWI male mice at P30 and P15 and their WT male littermates were used for experiments, while the TWI-Het littermates for the TWI colony maintenance31 (link), 42 (link). Surgical procedures for fixation were performed under urethane anesthesia (Sigma, 0.8 ml/hg), and all efforts were made to minimize mice suffering.
Most recents protocols related to «Males»
Example 3
Moulded Silicone Pressure Sensitive Adhesive Body:
Dow Corning 7-9800 A&B (mixing ration between A and Bis 1:1 by weight) were used for production of a PDMS based adhesive body. A mould having a triangular shape (each side of the triangular mould having a distance of 300 mm, the center part having a thickness of 0.5 mm and the edge having a thickness of 0.1 mm) was used. The components were thoroughly mixed and applied on a 50 μm cover layer of silicone rubber lining in the female part of a triangular mould and a male mould part was placed on top, said part lined with a low density polyethylene release liner. The adhesive was cured in an oven at 100 degree C. for 15 minutes. After curing the adhesive was punched out of the mould and a dent in the centre of the adhesive body device for embedment of an electronic sensing system was punched out.
Example 6
Tg32 mice were homozygous, 8 week old, males. There were 4 mice per test article group. The test articles included CDA1-WT, CDA1-FcMut008, and CDA1-FcMut015. The mice were dosed at 10 mg/Kg by IV administration. Data were collected at thirteen time points (1 h, 8 h, 1 d, 2 d, 3 d, 4 d, 6 d, 8 d, 10 d, 13 d, 16 d, 19 d, and 22 d). Human IgG was quantified by ELISA using an anti-hIgG polyclonal antibody.
Tg32 is a human FcRn transgenic mouse model that can be used in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies. Monoclonal antibody clearance in Tg32 homozygous mice has the strongest correlation to monoclonal antibody clearance in humans (Avery et al. MAbs. 2016; 8(6):1064-78).
CDA1 (actoxumab) is known to have a half-life of >25 days in human. In vivo evaluation with additional mAbs in Tg32 model was performed. The different constructs can also be evaluated on Tg276 mice which are reported to have increased half-life differences between IgG variants. The results are shown in Table 2 and
Example 2
Twenty-eight (28) healthy, adult male and female (non-childbearing potential) subjects were enrolled in the study in total; 14 subjects in each study part (Parts 1 and 2). A minimum of 8 female subjects were enrolled in the study (i.e., a minimum of 4 female subjects per study part). Each subject participated in either Part 1 or Part 2, but not both.
Part 1
On Day 1 of Treatment Period 1, a single oral dose of 20 mg mitapivat sulfate was administered. Serial blood samples for plasma assay of mitapivat concentrations and its CYP3A4 metabolite, referred to herein as the “Metabolite” (structure below),
In Treatment Period 1, mitapivat sulfate was administered orally with approximately 240 mL of water. In Treatment Period 2, on Days 1 to 4, itraconazole was administered alone immediately followed by approximately 220 mL of water, and on Day 5, itraconazole was administered first (no water) and was immediately followed by mitapivat sulfate administration with approximately 220 mL of water. Study drugs (mitapivat sulfate and itraconazole) were administered following an overnight fast of at least 10 hours on Day 1 of Treatment Period 1 (mitapivat sulfate only) and Day 5 of Treatment Period 2 (mitapivat sulfate and itraconazole), and subjects remained fasted for 4 hours after dosing. On all other dosing days, itraconazole was administered following a predose fast of at least 4 hours and subjects remained fasted for at least 2 hours after dosing.
Part 2
On Day 1 of Treatment Period 1, a single oral dose of 50 mg mitapivat sulfate was administered. Serial blood samples for plasma assay of mitapivat and the Metabolite concentrations were collected from predose to 120 hours following administration of mitapivat sulfate. In Treatment Period 2, an oral dose of 600 mg rifampin was administered QD for 12 consecutive days (Day 1 through Day 12 of Treatment Period 2) with a single oral dose of 50 mg mitapivat sulfate coadministered on Day 8. Serial blood samples for plasma assay of mitapivat sulfate and the Metabolite concentrations were collected from predose to 120 hours following coadministration of mitapivat and rifampin on Day 8.
In Part 2, study drugs were administered with approximately 240 mL of water on all dosing days including the coadministration of mitapivat sulfate and rifampin on Day 8 of Treatment Period 2. Mitapivat sulfate and rifampin was administered following an overnight fast of at least 10 hours on Day 1 of Treatment Period 1 (mitapivat sulfate only) and Day 8 of Treatment Period 2 (both mitapivat sulfate and rifampin) and subjects remained fasted for 4 hours after dosing. On all other dosing days, rifampin was administered following a predose fast of at least 4 hours and subjects remained fasted for at least 2 hours after dosing. There was a washout period of 7 days between the mitapivat sulfate dose in Treatment Period 1 and the first itraconazole (Part 1) or rifampin (Part 2) dose in Treatment Period 2. All study drugs were consumed within 5 minutes for both Part 1 and Part 2.
Example 4
A male 58-year-old subject suffering from a migraine ingested a capsule comprising 1000 mg citric acid and a capsule comprising 1200 mg KNO3, 200 mg elemental magnesium, and 50 mg elemental zinc. Within 5 minutes of ingesting both capsules, the subject saw alleviation of migraine symptoms. 30 minutes after ingesting the capsules, the subject reported that the migraine symptoms had disappeared.
Example 2
The antidepressant effects of the yeast Saccharomyces boulardii are evaluated by chronic administration to adult male CD1 mice in the forced swimming test.
The forced-swimming test, well known to the skilled person, is used to measure the antidepressant effects of a pharmacological compound. This test is based on the work of Porsolt et al. (1977) Act. Int. Pharmacodyn. Ther. 229:327-336 and has since been classically used to predict the clinical efficacy of antidepressant compounds.
Briefly, this test takes place in a cylindrical container filled with water (water height 10 cm) at 23° C. The mouse is placed in this container for 6 minutes, and the duration of immobility of the animal is measured for the last 4 minutes.
The antidepressant compounds administered prior to this test significantly reduce the immobility time of the animals.
Top products related to «Males»
More about "Males"
From the production of sperm to the development of stronger muscle mass, the male sex is defined by the XY chromosomes and a variety of secondary sexual traits.
Researchers can delve deeper into male-oriented studies by leveraging the power of PubCompare.ai, a leading AI platform that provides data-driven insights from the latest literature, preprints, and patents.
This tool can help identify the most effective products and methodologies to advance your research, whether you're working with C57BL/6J mice, Sprague-Dawley rats, or other relevant model organisms.
Explore the latest advancements in male biology, including insights from studies on C57BL/6 mice, FBS, and Male Sprague-Dawley rats.
Discover the optimal protocols and procedures for your male-focused research, informed by the wealth of data available through PubCompare.ai.
Stay ahead of the curve with the most up-to-date and accurate information on the male biological identity.
Harness the power of data-driven insights to optimize your research and drive breakthroughs in our understanding of this fascinating aspect of human physiology.